Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Depreciation & Amortization (CF): 2019-2024

Historic Depreciation & Amortization (CF) for MDxHealth (MDXH) over the last 6 years, with Dec 2024 value amounting to $3.1 million.

  • MDxHealth's Depreciation & Amortization (CF) rose 16.57% to $957,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 million, marking a year-over-year increase of 160.21%. This contributed to the annual value of $3.1 million for FY2024, which is 32.52% up from last year.
  • As of FY2024, MDxHealth's Depreciation & Amortization (CF) stood at $3.1 million, which was up 32.52% from $2.4 million recorded in FY2023.
  • In the past 5 years, MDxHealth's Depreciation & Amortization (CF) registered a high of $3.3 million during FY2020, and its lowest value of $1.4 million during FY2021.
  • For the 3-year period, MDxHealth's Depreciation & Amortization (CF) averaged around $2.4 million, with its median value being $2.4 million (2023).
  • As far as peak fluctuations go, MDxHealth's Depreciation & Amortization (CF) crashed by 57.20% in 2021, and later skyrocketed by 35.92% in 2023.
  • Over the past 5 years, MDxHealth's Depreciation & Amortization (CF) (MRY) stood at $3.3 million in 2020, then plummeted by 57.20% to $1.4 million in 2021, then rose by 22.02% to $1.7 million in 2022, then soared by 35.92% to $2.4 million in 2023, then surged by 32.52% to $3.1 million in 2024.
  • Its Depreciation & Amortization (CF) was $3.1 million in FY2024, compared to $2.4 million in FY2023 and $1.7 million in FY2022.